LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 14 of 497
Next
>>
>
326 to 350 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Withaferin A	0.04	uM	LJP6	2	G18	72	hr	1097	4023	3769	1.0672	1.0948
BT-20	Withaferin A	0.04	uM	LJP6	3	G18	72	hr	1097	3715	3769	0.9855	0.9796
BT-20	WYE-125132	0.04	uM	LJP6	1	L12	72	hr	1097	1782	3769	0.4727	0.2562
BT-20	WYE-125132	0.04	uM	LJP6	2	L12	72	hr	1097	1706	3769	0.4526	0.2278
BT-20	WYE-125132	0.04	uM	LJP6	3	L12	72	hr	1097	1813	3769	0.4810	0.2678
BT-20	WZ3105	0.04	uM	LJP5	1	D24	72	hr	1097	1723	3769	0.4571	0.2342
BT-20	WZ3105	0.04	uM	LJP5	2	D24	72	hr	1097	1675	3769	0.4444	0.2162
BT-20	WZ3105	0.04	uM	LJP5	3	D24	72	hr	1097	1986	3769	0.5269	0.3326
BT-20	XMD11-50	0.04	uM	LJP6	1	P12	72	hr	1097	2797	3769	0.7420	0.6361
BT-20	XMD11-50	0.04	uM	LJP6	2	P12	72	hr	1097	2931	3769	0.7776	0.6862
BT-20	XMD11-50	0.04	uM	LJP6	3	P12	72	hr	1097	3216	3769	0.8532	0.7929
BT-20	Y39983	0.04	uM	LJP6	1	P06	72	hr	1097	3397	3769	0.9012	0.8606
BT-20	Y39983	0.04	uM	LJP6	2	P06	72	hr	1097	3283	3769	0.8709	0.8179
BT-20	Y39983	0.04	uM	LJP6	3	P06	72	hr	1097	3586	3769	0.9513	0.9313
BT-20	YM 201636	0.04	uM	LJP5	1	N12	72	hr	1097	3717	3769	0.9861	0.9803
BT-20	YM 201636	0.04	uM	LJP5	2	N12	72	hr	1097	4561	3769	1.2100	1.2962
BT-20	YM 201636	0.04	uM	LJP5	3	N12	72	hr	1097	4260	3769	1.1301	1.1835
BT-20	ZSTK474	0.04	uM	LJP6	1	M18	72	hr	1097	3469	3769	0.9203	0.8875
BT-20	ZSTK474	0.04	uM	LJP6	2	M18	72	hr	1097	3510	3769	0.9312	0.9029
BT-20	ZSTK474	0.04	uM	LJP6	3	M18	72	hr	1097	3483	3769	0.9240	0.8928
BT-20	Afatinib	0.12	uM	LJP6	1	G23	72	hr	1097	3096	3769	0.8213	0.7480
BT-20	Afatinib	0.12	uM	LJP6	2	G23	72	hr	1097	2895	3769	0.7680	0.6727
BT-20	Afatinib	0.12	uM	LJP6	3	G23	72	hr	1097	3106	3769	0.8240	0.7517
BT-20	Sigma A6730	0.12	uM	LJP5	1	B23	72	hr	1097	3257	3769	0.8640	0.8082
BT-20	Sigma A6730	0.12	uM	LJP5	2	B23	72	hr	1097	3250	3769	0.8622	0.8056

|<
<<
Previous
Page 14 of 497
Next
>>
>
326 to 350 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)